Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
24
DTIL Quote, Financials, Valuation and Earnings
Last price:
$5.01
Seasonality move
:
-18.41%
Day range:
$4.89 - $5.19
52-week range:
$3.61 - $8.82
Dividend yield:
0%
P/E ratio:
3.41x
P/S ratio:
72.78x
P/B ratio:
4.03x
Volume:
172.6K
Avg. volume:
224.1K
1-year change:
-18.52%
Market cap:
$67.1M
Revenue:
$68.7M
EPS (TTM):
-$8.40
Analysts' Opinion
-
Consensus RatingPrecision BioSciences, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $32.50, Precision BioSciences, Inc. has an estimated upside of 542.29% from its current price of $5.06.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $19.00 representing 100% downside risk from its current price of $5.06.
Fair Value
-
According to the consensus of 4 analysts, Precision BioSciences, Inc. has 542.29% upside to fair value with a price target of $32.50 per share.
DTIL vs. S&P 500
-
Over the past 5 trading days, Precision BioSciences, Inc. has overperformed the S&P 500 by 3.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Precision BioSciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Precision BioSciences, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Precision BioSciences, Inc. reported revenues of $13K.
Earnings Growth
-
Precision BioSciences, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Precision BioSciences, Inc. reported earnings per share of -$1.84.
Enterprise value:
51.3M
EV / Invested capital:
1.12x
Price / LTM sales:
72.78x
EV / EBIT:
-1.63x
EV / Revenue:
73.55x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-0.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
-1.08x
Gross Profit (TTM):
-$2.1M
Return On Assets:
-67.8%
Net Income Margin (TTM):
-11977.36%
Return On Equity:
-188.9%
Return On Invested Capital:
-112.99%
Operating Margin:
-158976.92%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $52.3M | $75.1M | $698K | $576K | $13K | |
| Gross Profit | $43.3M | $69.7M | -$2.1M | -$435K | -$661K | |
| Operating Income | -$41M | -$16.2M | -$89.5M | -$21.3M | -$20.7M | |
| EBITDA | -$32M | -$10.8M | -$86.7M | -$20.3M | -$20M | |
| Diluted EPS | -$113.13 | $0.05 | -$8.40 | -$2.25 | -$1.84 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $183M | $225.4M | $145.9M | $110.5M | $51.7M | |
| Total Assets | $227.2M | $271.7M | $164.3M | $153.3M | $93.5M | |
| Current Liabilities | $36.5M | $61.1M | $50.6M | $12M | $15M | |
| Total Liabilities | $125.8M | $187.4M | $135.3M | $88.4M | $76.9M | |
| Total Equity | $101.4M | $84.4M | $29.1M | $64.9M | $16.6M | |
| Total Debt | $11.5M | $25.5M | -- | $29M | $27.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$97.5M | -$48.2M | -$75.7M | -$5.9M | -$15.3M | |
| Cash From Investing | $2.5M | -$76K | -$406K | -$64K | $17K | |
| Cash From Financing | $2.6M | $47.4M | $23.6M | $3.7M | $1.7M | |
| Free Cash Flow | -$100.4M | -$48.4M | -$76.2M | -$6M | -$15.3M | |
DTIL
Sector
Market Cap
$67.1M
$28.4M
Price % of 52-Week High
57.37%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-34.86%
-1.32%
1-Year Price Total Return
-18.52%
-22.19%
Beta (5-Year)
1.110
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.04
200-day SMA
Sell
Level
$5.19
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$5.48
Relative Strength Index (RSI14)
Sell
Level
40.87
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-73.6111
50-day SMA
Sell
Level
$6.02
MACD (12, 26)
Sell
Level
-0.38
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-4.1434)
Sell
CA Score
(Annual)
Level (-2.2088)
Sell
Beneish M-Score
(Annual)
Level (0.8084)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-2.8276)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.
Stock Forecast FAQ
In the current month, DTIL has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DTIL average analyst price target in the past 3 months is $32.50.
-
Where Will Precision BioSciences, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Precision BioSciences, Inc. share price will rise to $32.50 per share over the next 12 months.
-
What Do Analysts Say About Precision BioSciences, Inc.?
Analysts are divided on their view about Precision BioSciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Precision BioSciences, Inc. is a Sell and believe this share price will drop from its current level to $19.00.
-
What Is Precision BioSciences, Inc.'s Price Target?
The price target for Precision BioSciences, Inc. over the next 1-year time period is forecast to be $32.50 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DTIL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Precision BioSciences, Inc. is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of DTIL?
You can purchase shares of Precision BioSciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Precision BioSciences, Inc. shares.
-
What Is The Precision BioSciences, Inc. Share Price Today?
Precision BioSciences, Inc. was last trading at $5.01 per share. This represents the most recent stock quote for Precision BioSciences, Inc.. Yesterday, Precision BioSciences, Inc. closed at $5.06 per share.
-
How To Buy Precision BioSciences, Inc. Stock Online?
In order to purchase Precision BioSciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get DTIL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DTIL
Sector
P/E ratio
3.41x
23.66x
PEG ratio
0.00x
-0.01x
P/B ratio
4.03x
1.84x
Price / LTM sales
72.78x
1.60x
Growth Metrics
DTIL
Sector
Revenue growth
-97.74%
4.85%
Earnings growth
18.27%
11.15%
Revenue (5-year growth)
25.31%
6.45%
Earnings forecast
-$2.21
-$0.20
Profitability
DTIL
Sector
Profitability FY 2024
$64.1M
$3.6M
Return on invested capital
-112.99%
-30.98%
Return on assets
-67.8%
-27.62%
Return on equity
-188.9%
-36.69%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Feb
2
Balance Sheet
DTIL
Sector
Total cash
$44.9M
$27.2M
Short term investments
$413K
$25.7M
Total assets
$136.4M
$79.9M
Long term debt
$27.7M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
